Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 471

1.

Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.

Serpa Neto A, Veelo DP, Peireira VG, de Assunção MS, Manetta JA, Espósito DC, Schultz MJ.

J Crit Care. 2014 Feb;29(1):185.e1-7. doi: 10.1016/j.jcrc.2013.09.031. Epub 2013 Oct 22. Review.

PMID:
24262273
2.

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Mutter TC, Ruth CA, Dart AB.

Cochrane Database Syst Rev. 2013 Jul 23;(7):CD007594. doi: 10.1002/14651858.CD007594.pub3. Review.

PMID:
23881659
3.

Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.

He B, Xu B, Xu X, Li L, Ren R, Chen Z, Xiao J, Wang Y, Xu B.

Crit Care. 2015 Mar 19;19:92. doi: 10.1186/s13054-015-0833-9.

4.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I, Ker K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000567. doi: 10.1002/14651858.CD000567.pub6. Review.

PMID:
23450531
5.

New insights into fluid resuscitation.

Myburgh J, McIntyre L.

Intensive Care Med. 2013 Jun;39(6):998-1001. doi: 10.1007/s00134-013-2890-3. Epub 2013 Apr 5.

PMID:
23559078
6.

Hydroxyethyl starch for fluid resuscitation in critically ill patients.

Bagshaw SM, Chawla LS.

Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.

PMID:
23604905
7.

Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.

Müller RB, Haase N, Lange T, Wetterslev J, Perner A.

Acta Anaesthesiol Scand. 2015 Mar;59(3):329-36. doi: 10.1111/aas.12453. Epub 2014 Dec 18.

PMID:
25524831
8.

Fluid replacement with hydroxyethyl starch in critical care--a reassessment.

Hartog CS, Welte T, Schlattmann P, Reinhart K.

Dtsch Arztebl Int. 2013 Jun;110(26):443-50. doi: 10.3238/arztebl.2013.0443. Epub 2013 Jun 28. Review.

9.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000567. doi: 10.1002/14651858.CD000567.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;(2):CD000567.

PMID:
22696320
10.

Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.

Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA.

JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430. Review. Erratum in: JAMA. 2013 Mar 27;309(12):1229.

PMID:
23423413
11.

Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.

Leberle R, Ernstberger A, Loibl M, Merkl J, Bunz M, Creutzenberg M, Trabold B.

Injury. 2015 Jan;46(1):105-9. doi: 10.1016/j.injury.2014.08.039. Epub 2014 Sep 4.

PMID:
25240412
12.

Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.

Raiman M, Mitchell CG, Biccard BM, Rodseth RN.

Eur J Anaesthesiol. 2016 Jan;33(1):42-8. doi: 10.1097/EJA.0000000000000328. Review.

PMID:
26351826
13.

Hydroxyethyl starch in sepsis.

Haase NR.

Dan Med J. 2014 Jan;61(1):B4764.

PMID:
24393593
14.

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Dart AB, Mutter TC, Ruth CA, Taback SP.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007594. doi: 10.1002/14651858.CD007594.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD007594.

PMID:
20091640
15.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000567. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD000567.

PMID:
17943746
16.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000567. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD000567.

PMID:
15495001
17.

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group.; Scandinavian Critical Care Trials Group..

N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27. Erratum in: N Engl J Med. 2012 Aug 2;367(5):481.

18.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD000567. doi: 10.1002/14651858.CD000567.pub4. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD000567.

PMID:
21412866
19.

Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials.

Li L, Li Y, Xu X, Xu B, Ren R, Liu Y, Zhang J, He B.

Crit Care. 2015 Mar 10;19:79. doi: 10.1186/s13054-015-0815-y. Review.

20.

Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison.

Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS.

Crit Care Med. 2011 Jun;39(6):1335-42. doi: 10.1097/CCM.0b013e318212096a.

PMID:
21358396

Supplemental Content

Support Center